DE69903315T2 - Pharmazeutische zubereitungen enthaltend hydroxylansoprazol und deren verwendungen - Google Patents

Pharmazeutische zubereitungen enthaltend hydroxylansoprazol und deren verwendungen

Info

Publication number
DE69903315T2
DE69903315T2 DE69903315T DE69903315T DE69903315T2 DE 69903315 T2 DE69903315 T2 DE 69903315T2 DE 69903315 T DE69903315 T DE 69903315T DE 69903315 T DE69903315 T DE 69903315T DE 69903315 T2 DE69903315 T2 DE 69903315T2
Authority
DE
Germany
Prior art keywords
hydroxylansoprazole
pharmaceutical preparations
preparations containing
lansoprazole
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69903315T
Other languages
English (en)
Other versions
DE69903315D1 (de
Inventor
E Yelle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sunovion Pharmaceuticals Inc
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sepracor Inc filed Critical Sepracor Inc
Publication of DE69903315D1 publication Critical patent/DE69903315D1/de
Application granted granted Critical
Publication of DE69903315T2 publication Critical patent/DE69903315T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
DE69903315T 1998-07-22 1999-07-19 Pharmazeutische zubereitungen enthaltend hydroxylansoprazol und deren verwendungen Expired - Lifetime DE69903315T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9376298P 1998-07-22 1998-07-22
PCT/US1999/016322 WO2000004904A1 (en) 1998-07-22 1999-07-19 Pharmaceutical compositions comprising hydroxylansoprazole and uses thereof

Publications (2)

Publication Number Publication Date
DE69903315D1 DE69903315D1 (de) 2002-11-07
DE69903315T2 true DE69903315T2 (de) 2003-06-18

Family

ID=22240576

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69903315T Expired - Lifetime DE69903315T2 (de) 1998-07-22 1999-07-19 Pharmazeutische zubereitungen enthaltend hydroxylansoprazol und deren verwendungen

Country Status (9)

Country Link
US (3) US6335351B1 (de)
EP (1) EP1098648B1 (de)
JP (1) JP2002521336A (de)
AT (1) ATE225175T1 (de)
AU (1) AU763642B2 (de)
CA (1) CA2337886C (de)
DE (1) DE69903315T2 (de)
ES (1) ES2182554T3 (de)
WO (1) WO2000004904A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100434904B1 (ko) * 2002-05-30 2004-06-11 주식회사 대웅 안정화된 란소프라졸을 함유하는 장용성 제제

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6150978A (ja) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法

Also Published As

Publication number Publication date
ATE225175T1 (de) 2002-10-15
AU5218299A (en) 2000-02-14
EP1098648B1 (de) 2002-10-02
AU763642B2 (en) 2003-07-31
JP2002521336A (ja) 2002-07-16
US20020099079A1 (en) 2002-07-25
WO2000004904A1 (en) 2000-02-03
ES2182554T3 (es) 2003-03-01
CA2337886A1 (en) 2000-02-03
EP1098648A1 (de) 2001-05-16
US6335351B1 (en) 2002-01-01
CA2337886C (en) 2008-04-08
US20040077688A1 (en) 2004-04-22
DE69903315D1 (de) 2002-11-07
US7098224B2 (en) 2006-08-29

Similar Documents

Publication Publication Date Title
DE69006628D1 (de) Pharmazeutische Zusammensetzung, enthaltend Loratadin, Ibuprofen und Pseudoephedrin.
DK2455083T3 (da) Farmaceutisk sammensætning til dermal anvendelse omfattende calcipotriol og betamethason til behandling af psoriasis
NO20061736L (no) Krystallform av epotilon B
ATE551363T1 (de) Verwendung von antikörper gegen interleukin-4 rezeptor und deren zusammensetzungen
DE69802260D1 (de) Pharmazeutische Zusammensetzungen enthaltend Lactobacillus brevis und Lactobacillus salivarius zur Behandlung von Vaginainfektionen
NO923948L (no) Tiofensulfonamider som kan anvendes som karbonsyre-anhydraseinhibitorer
DK1053256T3 (da) Antistoffer mod Dødsreceptor 4 (DR4) og anvendelser deraf
BR0108402A (pt) Análogos de nucleosìdeo com base monocìclica carboxamidina modificado
NO20016198L (no) Orale farmasöytiske sammensetninger som inneholder taxaner og fremgangsmåter for anvendelse av samme i behandling
NO983003L (no) Vitronectin-reseptor-antagonister
EA201000643A1 (ru) Замещенное производное этилендиамина для лечения микобактериальных заболеваний и фармацевтическая композиция на его основе
DE69232323D1 (de) Verwendung von Adenosinantagonisten zur Vorbeugung und Behandlung von Pankreatitis und Ulcera
DE69818286D1 (de) Pyridylverbindungen und diese enthaltende pharmazeutische zubereitungen
ATE400258T1 (de) Transdermales buprenorphin-dosierschema zwecks schmerzstillung
HUP0103203A2 (hu) Azaadamantánszármazékok és ezeket tartalmazó gyógyszerkészítmények
SE0203825D0 (sv) Novel fused heterocycles and uses thereof
IT1298338B1 (it) Composizioni farmaceutiche per l'ulcera
DE69902657T2 (de) Hydroxyomeprazol-enthaltende zubereitungen und verwendungen
SE0003476D0 (sv) Compounds
DE69903315T2 (de) Pharmazeutische zubereitungen enthaltend hydroxylansoprazol und deren verwendungen
NO20010464D0 (no) Fremgangsmåter og sammensetninger for behandling av gastroösofrageal-reflukssyndrom
DK1075262T3 (da) Desmethylpantoprazolpræparater og -fremgangsmåder
DE68909555D1 (de) Pyridylketoximether-verbindung und diese enthaltende pharmazeutische zusammensetzung.
ATE106732T1 (de) Arzneimittelzubereitung, enthaltend stigmasta-4- en-3-on sowie deren verwendung.
DE60031385D1 (de) Pharmazeutische Zusammensetzungen von Antibiotika und Fruktan-Gemische

Legal Events

Date Code Title Description
8364 No opposition during term of opposition